Download full-text PDF |
Source |
---|
The objective of the present work was to estimate the clinical, prophylactic, and microbiological effectiveness of fusafungine applied for the treatment of acute rhinosinusitis (ARS) in the children that develops as a consequence of acute stenosing laryngotracheitis. The study included 61 children presenting with ARS and concomitant acute stenosing laryngotracheitis (ASLT) that were treated with fusafungine (Bioparox). Both tolerance and safety of this preparation were evaluated.
View Article and Find Full Text PDFVestn Otorinolaringol
February 2013
The objective of the study is to estimate the efficacy of Bioparox (fusafungine) when used for the treatment of the adult patients presenting with acute frontitis. Twenty two of the 45 patients with this condition were given adjuvant therapy using this preparation. It resulted in a decrease of the concentration of Staphylococcus aureus and S.
View Article and Find Full Text PDFThe objective of this study was to assess the appropriateness of using local antibacterial therapy in the postoperative period following rhinosurgical interventions based on the results of hemiluminescent, microbiological, and cytological studies. They included 20 patients who had underwent surgical intervention in the nasal cavity. The control group comprised 20 healthy subjects.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!